Incidence of Exacerbations and Hospitalizations Is Reduced and Time to Exacerbations Is Prolonged with Mometasone Furoate Dry Powder Inhaler Versus Beclomethasone Dipropionate Hydrofluoroalkane Aerosol in Patients with Mild Asthma

Beclomethasone Dipropionate Hydrofluoroalkane

Dry Powder Inhaler ◽

Mometasone Furoate ◽

Mild Asthma ◽

Dry Powder ◽

Effects of Mometasone Furoate Dry Powder Inhaler and Beclomethasone Dipropionate Hydrofluoroalkane and Chlorofluorocarbon on the Hypothalamic-Pituitary-Adrenal Axis in Asthmatic Subjects

CHEST Journal ◽

10.1378/chest.128.1.70 ◽

2005 ◽

Vol 128 (1) ◽

pp. 70-77 ◽

Cited By ~ 24

Author(s):

George P. Chrousos ◽

Lisa Ghaly ◽

Arthur Shedden ◽

Domenic G. Iezzoni ◽

Alan G. Harris

Keyword(s):

Dry Powder Inhaler ◽

Hypothalamic Pituitary Adrenal Axis ◽

Mometasone Furoate ◽

Dry Powder ◽

Hypothalamic Pituitary Adrenal ◽

Adrenal Axis ◽

Beclomethasone Dipropionate Hydrofluoroalkane ◽

Pituitary Adrenal Axis

Safety of Mometasone Furoate Dry Powder Inhaler and Comparison with Beclomethasone Dipropionate in Children with Asthma Previously Maintained on Inhaled Corticosteroids (ICS)

CHEST Journal ◽

10.1378/chest.126.4_meetingabstracts.912s ◽

2004 ◽

Vol 126 (4) ◽

pp. 912S

Author(s):

Michael Noonan ◽

Jonathan Corren ◽

Jeffrey Leflein

Keyword(s):

Inhaled Corticosteroids ◽

Dry Powder Inhaler ◽

Mometasone Furoate ◽

Dry Powder ◽

Children With Asthma

Long-term safety of Mometasone Furoate administered via a dry powder inhaler in children: Results of an open-label study comparing Mometasone Furoate with Beclomethasone Dipropionate in children with persistent asthma

BMC Pediatrics ◽

10.1186/1471-2431-9-43 ◽

2009 ◽

Vol 9 (1) ◽

Cited By ~ 11

Author(s):

Michael Noonan ◽

Jeffrey Leflein ◽

Jonathan Corren ◽

Heribert Staudinger

Keyword(s):

Dry Powder Inhaler ◽

Persistent Asthma ◽

Mometasone Furoate ◽

Dry Powder ◽

Open Label ◽

Open Label Study ◽

Label Study

Once-daily evening dosing with mometasone furoate dry-powder inhaler reduces overnight and early morning symptoms of mild to moderate asthma

10.1016/s0091-6749(03)80754-6 ◽

2003 ◽

Vol 111 (2) ◽

pp. S217 ◽

Cited By ~ 1

Author(s):

J. Corren ◽

P.V. Perin ◽

S.P. Galant ◽

H. Staudinger ◽

H. Sacks

Keyword(s):

Dry Powder Inhaler ◽

Early Morning ◽

Mometasone Furoate ◽

Dry Powder ◽

Once Daily ◽

Moderate Asthma ◽

Morning Symptoms

47 Pediatric airflow profiles with the new mometasone furoate dry powder inhaler (MF-DPI)

10.1016/s0091-6749(00)90479-2 ◽

2000 ◽

Vol 105 (1) ◽

pp. S16 ◽

Cited By ~ 3

Author(s):

D SKONER

Keyword(s):

Dry Powder Inhaler ◽

Mometasone Furoate ◽

Dry Powder

COMPARATIVE EFFECTIVENESS OF MOMETASONE FUROATE INHALATION POWDER VERSUS BECLOMETHASONE DIPROPIONATE HYDROFLUOROALKANE AEROSOL IN THE TREATMENT OF CONTROLLER-NAIVE PATIENTS WITH MILD, PERSISTENT ASTHMA

CHEST Journal ◽

10.1378/chest.136.4_meetingabstracts.8s-a ◽

2009 ◽

Vol 136 (4) ◽

pp. 8S

Author(s):

Prakash Navaratnam ◽

Eduardo R. Urdaneta ◽

John McLaughlin ◽

Howard S. Friedman

Keyword(s):

Comparative Effectiveness ◽

Persistent Asthma ◽

Mometasone Furoate ◽

Beclomethasone Dipropionate Hydrofluoroalkane ◽

Mild Persistent Asthma ◽

Inhalation Powder

46 Airflow profiles and inhaler technique with the new mometasone furoate dry powder inhaler (MF-DPI)

10.1016/s0091-6749(00)90478-0 ◽

2000 ◽

Vol 105 (1) ◽

pp. S16 ◽

Cited By ~ 2

Author(s):

D MILLER

Keyword(s):

Dry Powder Inhaler ◽

Mometasone Furoate ◽

Inhaler Technique ◽

Dry Powder

Comparison of a dry powder inhaler (DPI) to a pressurized metered-dose inhaler (pMDI) formulation of extra fine beclomethasone dipropionate/formoterol fumarate/glycopyrronium bromide (BDP/FF/GB) in patients with COPD: The TRI-D study

10.1183/13993003.congress-2020.3246 ◽

2020 ◽

Author(s):

Kai Michael Beeh ◽

Piotr Kuna ◽

Isabelle Viaud ◽

Alessandro Guasconi ◽

Massimo Corradi ◽

...

Keyword(s):

Dry Powder Inhaler ◽

Dose Inhaler ◽

Metered Dose Inhaler ◽

Dry Powder ◽

Glycopyrronium Bromide ◽

Metered Dose ◽

Pressurized Metered Dose Inhaler ◽

Formoterol Fumarate

Effects of Mometasone Furoate Administered Via a Dry Powder Inhaler Once Daily in the Evening on Nocturnal Lung Function and Sleep Parameters in Patients with Moderate Persistent Asthma

Clinical Drug Investigation ◽

10.2165/0044011-200929010-00005 ◽

2009 ◽

Vol 29 (1) ◽

pp. 51-58

Author(s):

John H Krouse ◽

Helene J Krouse ◽

James J Janisse

Keyword(s):

Lung Function ◽

Dry Powder Inhaler ◽

Persistent Asthma ◽

Mometasone Furoate ◽

Dry Powder ◽

Once Daily ◽

Sleep Parameters ◽

Moderate Persistent Asthma

Effects of once-daily evening dosing with mometasone furoate dry-powder inhaler on symptom control in mild to moderate asthma

10.1016/s0091-6749(03)80756-x ◽

2003 ◽

Vol 111 (2) ◽

pp. S218

Author(s):

A. D'Urzo ◽

B. Prenner ◽

M. Vandewalker ◽

H. Staudinger ◽

H. Sacks

Keyword(s):

Symptom Control ◽

Dry Powder Inhaler ◽

Mometasone Furoate ◽

Dry Powder ◽

Once Daily ◽

Moderate Asthma